S ystemic lupus erythematosus (SLE)
5 is a systemic autoimmune disease with diverse and variable clinical manifestations, including the development of an immune complex-mediated glomerulonephritis (reviewed in Refs. 1 and 2). Although SLE can occur at nearly any age, women in their childbearing years show an increased incidence, suggesting that estrogens enhance disease development. The hallmark of lupus is elevated serum levels of IgG antinuclear Abs. F 1 hybrids of NZB and NZW mice (BWF 1 mice) develop severe glomerulonephritis associated with high serum levels of IgG antinuclear autoantibodies, remarkably similar to human SLE (3) . Additionally, female BWF 1 mice are more prone to disease than males, which is also similar to the sex-specific susceptibility observed in human SLE patients (4 -6) .
The genetic basis of disease in BWF 1 mice is complex, and no particular gene is necessary or sufficient for disease expression (7, 8) . However, the MHC and an NZB lupus susceptibility locus on distal chromosome 1 (named Nba2 for NZB autoimmunity 2) have shown consistent linkage with lupus traits in multiple mapping studies (7, 9 -14) . In one cross, Nba2 in combination with the H2 d/z MHC haplotype, accounted for Ͼ90% of the genetic contribution to IgG autoantibody production and lupus nephritis (kidney disease) (11) . Genetic linkage and association studies have demonstrated that MHC heterozygosity is disease enhancing compared with homozygosity for either the H2 d (NZB) or H2 z (NZW) haplotype in BWF 1 animals (7, 9 -11, 13-20) .
The autoimmune phenotype in B6 mice congenic for the Nba2 interval (B6.Nba2 mice) is characterized by elevated serum levels of IgG antinuclear autoantibodies (21) . However, these mice do not develop manifestations of severe lupus nephritis, including proteinuria or renal insufficiency. In contrast, (B6.Nba2 ϫ NZW)F 1 mice produce autoantibodies and develop nephritis, indicating that MHC heterozygosity, NZW-encoded non-MHC genes, or both are required in addition to the Nba2 interval for full disease penetrance. The studies described herein explore the effect of different MHC haplotypes and heterozygosity on disease expression in Nba2 congenic mice with and without the addition of NZW-encoded non-MHC genes. In addition, both male and female mice were evaluated to determine whether Nba2 congenic mice maintain the female sex-dependent susceptibility that has been observed in BWF 1 mice.
The results indicate that H2 b/z heterozygosity in the Nba2 congenic is not sufficient for the development of severe kidney disease. In addition, homozygosity for H2 z in (B6.Nba2 ϫ NZW)F 1 mice prevented antinuclear Ab production and nephritis. Comparison of IgG autoantibody production, immune complex (IC), and complement deposition in the kidney and severe proteinuria in MHC-matched B6.Nba2 and (B6.Nba2 ϫ NZW)F 1 mice provided additional insight into the role of NZW-encoded, non-MHC genes. Furthermore, female mice produced greater amounts of autoantibodies and were more susceptible to lupus nephritis than male mice in each genetic system. These studies provide further insight into the impact of the MHC on the disease process and also provide a simplified genetic system for understanding sex-related differences in lupus susceptibility and lupus pathogenesis.
Materials and Methods

Mice and detection of proteinuria
, and B6 (H2 b/b ) mice were obtained from The Jackson Laboratory and were maintained in the animal care facility at University of Colorado Health Sciences Center (Denver, CO) in accordance with guidelines approved by the animal care and use committee. B6.Nba2 congenic mice were generated by backcrossing an NZB interval on distal chromosome 1 to the B6 strain as previously described (21) . B6.H2 d/d mice were obtained from The Jackson Laboratory, and B6 mice were made congenic for the NZW H2 z/z (B6.H2 z/z ) as previously described (22) .
Study mice were followed for the development of lupus nephritis by measuring proteinuria at monthly intervals as previously described (9, 11, 14) . Mice with Ն2ϩ (100 mg/dl) on at least two consecutive occasions before 12 mo of age were designated as positive for high grade proteinuria and severe renal disease. The validity of using proteinuria to document severe renal disease and predict mortality from renal failure in New Zealand hybrid mice has been previously demonstrated (9, 11, 14) .
Measurement of IgG autoantibodies and total IgG Levels
Serum autoantibody levels to chromatin, dsDNA, ssDNA, and total histones were determined by ELISA as previously described (13, 14) . Serum samples were tested at a dilution of 1/300. All assays were performed in duplicate, and OD determinations were converted to units per milliliter by comparison with a standard curve obtained with mAbs to the appropriate nuclear Ag as previously described (13, 14) . Animals were considered positive for antinuclear Abs if levels were 2 SD above the median levels in age-matched B6 animals. Serum levels of total IgG were also determined by ELISA as previously described (13) using sera diluted 1/100,000. OD determinations were converted to units per milliliter by comparison with a standard curve obtained with known concentrations of polyclonal IgG (MP Biomedical).
Immunohistochemistry
Kidneys were snap-frozen in Tissue-Tek (OCT) and were kept at Ϫ70°C until sectioning. Sections were blocked with 10% nonimmune goat serum before staining. Five-micron sections were cut, fixed in acetone, and stained for total IgG deposition using FITC-conjugated rabbit anti-mouse IgG Abs (MP Biomedicals). Staining intensity was evaluated using ImagePro software (version 4.5; Media Cybernetics) on digitalized images acquired through a Pixera CL600 color CCD camera and an Olympus BX51 microscope. All pictures were taken at identical conditions. Blinded scores were determined for IgG and complement C3 staining using the following 0 -4 scale: 0, no detectable staining; 0.5, trace staining in mesangium only; 1, staining in mesangium only (Ͻ50% of glomeruli); 2, staining in mesangium only (Ͼ50% of glomeruli); 3, strong staining in mesangium (Ͼ50% of glomeruli) with occasional staining of capillary loops; and 4, strong staining in mesangium (Ͼ50% of glomeruli) with widespread staining of capillary loops.
Statistical analysis
The statistical significance of differences in autoantibody levels and degree of IgG deposition between groups of mice was determined using the nonparametric Mann-Whitney U test. A survival curve comparison analysis was used to determine the statistical significance of proteinuria rates between different groups of mice.
Results
Effect of MHC haplotype on autoantibody production and nephritis in B6.Nba2 mice
Many studies have demonstrated the importance of MHC haplotype in mouse lupus, especially in the BWF 1 model (7, 9 -20) . Therefore, we assessed autoantibody production in B6. B6.Nba2 (H2 b/b ) mice produced high levels of IgG antinuclear autoantibodies, yet did not develop lupus nephritis. However, when these congenic mice were crossed to NZW (H2 z/z ), severe lupus nephritis ensued. To determine whether the NZW contribution to lupus nephritis could be explained by inheritance of the H2 z allele alone, we compared the incidence of severe proteinuria between H2 b/b and H2 b/z B6.Nba2 mice and (B6.Nba2 ϫ NZW)F 1 mice. Beginning at 5-6 mo, the percentage of (B6.Nba2 ϫ NZW)F 1 (H2 b/z ) mice with severe proteinuria progressively increased, and at 12 mo of age, 80% of these mice had developed severe proteinuria (Fig. 2) . In contrast, by 12 mo of age, Ͻ10% of the H2 b/b and H2 b/z B6.Nba2 mice had developed severe proteinuria. These data indicate that inheritance of the H2 b/z MHC haplotype without additional NZW-encoded genes is not sufficient for the development of lupus nephritis in this model.
Autoantibody levels and immune complex deposition in the kidneys of MHC-matched B6.Nba2 and (B6.Nba2 ϫ NZW)F 1 mice
Potential mechanisms for how NZW-encoded non-MHC genes might enhance the development of glomerulonephritis in (B6.Nba2 ϫ NZW)F 1 mice include 1) enhanced autoantibody production leading to increased IC deposition; 2) production of additional pathogenic autoantibody specificities with increased IC deposition; 3) increased susceptibility to IC deposition in the kidney; and 4) enhanced damage-inducing inflammatory responses to deposited ICs (23) . To help differentiate among these possibilities, we first compared the levels of IgG antinuclear autoantibodies in H2 b/z B6.Nba2 and (B6.Nba2 ϫ NZW)F 1 mice. (B6.Nba2 ϫ NZW)F 1 mice produced more anti-chromatin ( p ϭ 0.003), antihistone ( p ϭ 0.003), and anti-ssDNA ( p ϭ 0.05) Abs, but not anti-dsDNA Abs (Fig. 3A) . F 1 mice also had elevated total IgG levels compared with MHC-matched B6.Nba2 mice (6.2 Ϯ 0.43 vs 2.2 Ϯ 0.17 U/ml).
We next assessed the extent of IgG and C3 deposition in the kidneys of B6.Nba2 (H2 b/b and H2 b/z ) mice compared with (B6.Nba2 ϫ NZW)F 1 mice. Surprisingly, both 12-mo-old proteinuria-free B6.Nba2 mice and 7-mo-old proteinuria-positive F 1 mice showed extensive IgG and C3 deposition in glomeruli in both mesangial and capillary loop areas (Fig. 3B ). As expected, B6 (negative control) glomeruli exhibited only trace amounts of IgG or C3 deposition (Fig. 3B) . The extent of kidney IgG deposition was scored on a 0 -4 scale. Overall, scores were greater for F 1 mice (Fig. 3C) . However, scores overlapped between the two groups of mice, despite the nonoverlapping propensities to develop severe proteinuria.
MHC contribution to nephritis and autoantibody production in (B6.Nba2 ϫ NZW)F 1 and (B6 ϫ NZW)F 1 mice: prevention of disease in H2 z/z mice
The above-described studies indicated that NZW-encoded non-MHC genes are required for renal disease in the context of Nba2. We therefore studied the influence of H2 b/z , H2 d/z , and H2 z/z MHC haplotypes on autoantibody production and kidney disease in (B6.Nba2 ϫ NZW)F 1 mice. As shown in Fig. 4A , the frequency of severe proteinuria in H2 b/z (B6.Nba2 ϫ NZW)F 1 mice progressed gradually, such that 80% of the mice were positive by 12 mo. In a similar pattern, disease progressively developed in H2 d/z (B6.Nba2 ϫ NZW)F 1 mice, with 44% positive by 12 mo. In contrast, none of the H2 z/z (B6.Nba2 ϫ NZW)F 1 mice developed disease ( p ϭ 0.002). No (B6 ϫ NZW)F 1 mouse in the control groups bearing any of these haplotypes developed severe renal disease during the 12-mo study period (Fig. 4A) , confirming that disease development in F 1 mice was dependent on the presence of Nba2.
The lack of lupus nephritis in the H2 z/z (B6.Nba2 ϫ NZW)F 1 animals correlated with low IgG autoantibody production (Fig. 4,  B-E) . Only a few mice had anti-chromatin autoantibodies slightly above background, and none was positive for autoantibodies to dsDNA, ssDNA, or total histones. In contrast nearly all H2 b/z and H2 d/z (B6.Nba2 ϫ NZW)F 1 mice were positive for autoantibodies to chromatin (Fig. 4D) . In addition, 63 and 78% were positive for anti-dsDNA autoantibodies, 75 and 67% for anti-ssDNA autoantibodies, and 100 and 56% for anti-histone autoantibodies, respectively (Fig. 4, B-E) . Only rare F 1 mice without Nba2 developed elevated IgG autoantibody levels.
Autoantibody production and disease in female vs male B6.Nba2 and (B6.Nba2 ϫ NZW)F 1 mice.
Past studies have shown that female BWF 1 mice exhibit a greater susceptibility to autoantibody production and lupus nephritis than male mice (4 -6). To determine whether the lupus-like disease associated with the Nba2 locus (derived from the NZB parent) still maintains this influence of gender, autoantibody levels and the incidence of proteinuria in both male and female animals were assessed. The current studies showed that female B6.Nba2 mice produced higher levels of anti-dsDNA ( p ϭ 0.03), anti-ssDNA ( p ϭ 0.02), anti-chromatin ( p ϭ 0.03), and anti-histone autoantibodies ( p ϭ 0.05) than male B6.Nba2 mice (Fig. 5) .
Enhancement of autoantibody production in females was also apparent in (B6.Nba2 ϫ NZW)F 1 mice (Fig. 6) . Female (B6.Nba2 ϫ NZW)F 1 mice produced more anti-ssDNA ( p ϭ 0.0003), anti-chromatin ( p Ͻ 0.0001), anti-dsDNA ( p ϭ 0.008), and anti-histone ( p ϭ 0.0003) autoantibodies than male (B6.Nba2 ϫ NZW)F 1 mice in the context of the H2 b/z MHC haplotype (Fig. 6A) . Total IgG levels were also 2-fold higher in H2 b/z female compared with male (B6.Nba2 ϫ NZW)F 1 mice (data not shown). In the context of the H2 d/z MHC haplotype, female mice produced more anti-chromatin ( p ϭ 0.001), anti-dsDNA ( p ϭ 0.002), and anti-ssDNA ( p ϭ 0.03) autoantibodies than male mice (Fig. 6B) .
Female (B6.Nba2 ϫ NZW)F 1 mice also developed more severe renal disease (Fig. 6C) . About 20% of female H2 b/z (B6.Nba2 ϫ NZW)F 1 mice developed severe proteinuria by 6 mo, and by 12 mo, 80% were positive. In contrast, only 20% of male (B6.Nba2 ϫ 
Discussion
The production of pathogenic IgG autoantibodies and the development of lupus nephritis in BWF 1 mice are dependent upon both CD4 ϩ T cells and MHC class II molecules (reviewed in Refs. 1 and 2). Studies have also shown that heterozygosity for both parental MHC haplotypes (H2 d/z ), compared with H2 d/d or H2 z/z , is important for development of fatal lupus nephritis (7, 9 -11, 13-20) . In addition, genetic linkage studies have shown that the most important dominant NZW contribution to disease is closely linked to the MHC (H2 z ) (7, 9, 11, 13, 18) . The current investigations were designed to clarify the importance of H2 z in the development of glomerulonephritis in Nba2 congenic mice, because (B6.Nba2 ϫ NZW)F 1 (H2 b/z ) mice develop glomerulonephritis, whereas B6.Nba2 (H2 b/b ) mice do not. Inheritance of H2 d/z was not sufficient for the development of glomerulonephritis in B6.Nba2 mice. Furthermore, homozygosity for H2 z was not permissive for either autoantibody production or glomerulonephritis, and H2 b/b appeared to be the most autoantibody-promoting MHC type. In these studies we noted considerable deposition of IgG and complement in the glomeruli of B6.Nba2 mice, supporting the hypothesis that their complete absence of glomerulonephritis might be related to missing NZW-encoded non-MHC genes downstream of this process. In additional studies, we found that the female vs male enhancement of disease in BWF 1 mice was also operative in B6.Nba2 and (B6.Nba2 ϫ NZW)F 1 mice regardless of MHC haplotype. Together, the current studies clarify the genes necessary for autoantibody production vs nephritis in BWF 1 mice and provide a simplified system to understand the pathogenesis of disease. z/z was completely suppressive of both autoantibody production and disease. The relative disease-promoting effect of H2 b compared with other haplotypes has been noted in other lupus-prone mouse strains, such as B6-Fas lpr mice (24, 25) , BXSB mice (26, 27) , certain backcross studies of NZB and NZW mice (16, 22, 28, 29) , and even some knockout models of lupus (30) . In contrast to H2 z and H2 d , the H2 b haplotype does not allow expression of an IE-␣ protein and does not express an I-E molecule (31) . With regard to this difference, other investigators have observed partial prevention of mouse lupus in mice with high levels of I-E expression (24, 32, 33) . Studies have suggested that peptides derived from I-E d and I-E z can prevent autoantibody production, perhaps through blocking of I-A presentation of other self peptides (24, (32) (33) (34) .
The marked prevention of autoantibody production and disease by homozygosity for H2 z probably relates to mechanisms additional to I-E expression. For example, in the current studies, increased autoantibody production in H2 d/z vs H2 z/z F 1 mice cannot easily be explained by levels of I-E, because both haplotypes encode functional I-E molecules about equally (22) . Previous studies from our laboratory suggested that H2 z alone may not be efficient at presenting certain types of self Ags compared with other haplotypes (18) . Furthermore, in separate studies, B6.Nba2 mice heterozygous for deficiency of Ab b (i.e., Ab ϩ/Ϫ ) mice produced higher amounts of autoantibodies than wild-type B6.Nba2 ϩ/ϩ (Ab ϩ/ϩ ) mice, consistent with the idea that lower levels of class II molecules (as would be the case for each class II molecule in a mouse heterozygous for MHC) reduces the numbers of T cells that are negatively selected in the thymus (35) .
The lack of antinuclear Abs and glomerulonephritis in our studies of H2 z/z B6.Nba2 mice almost certainly relates to studies by Wakeland and colleagues (36) showing that the strongest diseasesuppressor locus (Sles1) mapped to the H2 z MHC region. In their studies, Sles1 also inhibited disease at the level of autoantibody production by congenic mice. Nevertheless, Sles1 is not sufficient to inhibit disease in every genomic context, because NZM2410 (H2 z/z ) mice produce autoantibodies and develop glomerulonephritis. Our study design also localizes the position of Sles1, because the congenic interval includes only 1 cM of NZW genomic DNA proximal and 4 cM distal to the H2 z locus (22) . Novel aspects of the H2 z locus have been identified. For example, studies have described a novel allele of the factor B gene (class III region) in H2 z vs other haplotypes that affects activation of the alternative complement pathway in the kidney (37) .
Several explanations are possible for why B6.Nba2 mice do not develop glomerulonephritis. The current studies show that the levels of autoantibodies to chromatin and its constituents are lower in B6.Nba2 than in (B6.Nba2 ϫ NZW)F 1 mice, and it is possible that the B6.Nba2 levels do not achieve a threshold sufficient for disease. A second possibility is that different autoantibody specificities, critical for nephritis, are produced in F 1 , but not B6.Nba2 or H2 b/z B6.Nba2, mice. Studies involving NZM.C57Lc4 mice, which develop a fatal glomerulonephritis in the absence of autoantibodies to dsDNA and other antinuclear Abs, support this possibility (38) . Nevertheless, we observed prominent IgG and C3 deposition in the glomeruli of B6.Nba2 mice, suggesting that the block of fatal glomerulonephritis was at a level downstream of autoantibody production and IC deposition. Although the extent of deposition was not as diffuse as that observed in the F 1 mice, and levels in F 1 mice might continue to increase well beyond B6.Nba2 levels, our results suggest that at least one component of the NZW non-MHC contribution to disease in the F 1 is related to mechanisms of inflammation or destruction after IC deposition and complement activation. The data are consistent with recent studies suggesting that NZW mice are more susceptible than other strains to nephrotoxic serum-mediated glomerulonephritis and glomerular damage (39) . It has also been well demonstrated that genetic defects (and probably polymorphisms) can affect glomerulonephritis after the stage of IC deposition and complement activation (40) .
These studies also showed that female mice, whether B6.Nba2 or (B6.Nba2 ϫ NZW)F 1 , develop increased levels of autoantibodies and nephritis compared with male counterparts. Previous studies in humans and BWF 1 mice suggested that the effects of gender are related to sex hormones, both disease-suppressive effects of androgens and disease-enhancing effects of estrogens (1, 4 -6, 41, 42) . One major candidate gene for Nba2 is IFN-inducible gene 202 (Ifi202), which encodes a protein that inhibits apoptosis (21, 43) . Preliminary gene expression studies indicated an enhancing effect of estrogens on Ifi202 gene expression (D. Choubey, M. R. Gubbels, and B. L. Kotzin, unpublished observations), and this may be involved in their enhancing effect on disease. However, the consistent effects of sex hormones in different lupus models, including single-locus models such as Sle1 mice (36) , suggest that the effects of sex hormones on gene expression involve separate pathways that can consistently interact with nearly any group of lupus susceptibility genes.
In summary, the current studies showed that the development of disease in (B6.Nba2 ϫ NZW)F 1 compared with B6.Nba2 mice depends on NZW-encoded non-MHC genes. Additionally, H2 z homozygosity suppressed autoantibody production in these models, which may be dependent upon multiple genes within the MHC region. In these studies, the lack of nephritis in B6.Nba2 mice appeared to be partly independent of IC deposition in the kidney, suggesting that a component of the NZW genetic contribution required for kidney pathogenesis acts downstream of IC deposition. Whether this effect is dependent on sex hormones is unknown, because female mice exhibited both higher levels of autoantibodies and increased incidence of fatal lupus nephritis than male mice regardless of genetic background or MHC haplotype.
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